KING PHARMACEUTICALS,
INC.
LONG-TERM PERFORMANCE UNIT AWARD
CERTIFICATE
(ONE-YEAR PERFORMANCE CYCLE)
This Certificate,
when executed by a duly authorized officer of King Pharmaceuticals,
Inc. (the “Company”), evidences the grant by the
Company to the Participant named below of a Long-Term Performance
Unit Award.
|
|
|
|
|
|
|
|
|
Name of
Participant:
|
|
[Participant
Name]
|
|
|
|
|
|
|
|
|
|
Social Security
Number of Participant:
|
|
[Social
Security Number]
|
|
|
|
|
|
|
|
|
|
Date of
Grant:
|
|
[Grant
Date]
|
|
|
|
|
|
|
|
|
|
Type of
Grant:
|
|
[Grant
Type]
|
|
|
|
|
|
|
|
|
|
Target Number
of Long-Term Performance Units:
|
|
[Number of
Shares Granted]
|
|
|
|
|
|
|
|
|
|
Performance
Cycle:
|
|
The Performance
Cycle shall begin on January 1, 2009 and end on December 31,
2009.
|
|
|
|
|
|
|
|
|
|
Vesting
Period:
|
|
The Vesting
Period shall begin on January 1, 2010 and end on
December 31, 2011, except as otherwise set forth in the
Long-Term Performance Unit Award Agreement.
|
|
|
|
|
|
|
|
|
|
Date of
Payment:
|
|
Between January
1 and March 15, 2011, except as otherwise set forth in the
Long-Term Performance Unit Award Agreement.
|
|
|
|
|
|
|
|
|
|
Performance
Goals:
|
|
|
The number of Long-Term Performance
Units earned by the Participant shall be determined in accordance
with the following grid. If the actual performance results fall
between two of the categories listed below, straight-line
interpolation will be used to determine the amount earned.
Notwithstanding any other provision of this Certificate or the
Long-Term Performance Unit Award Agreement, upon the completion of
the Performance Cycle, the Committee may, in its sole discretion,
reduce the number of Long-Term Performance Units that are actually
earned by the Participant, irrespective of whether adherence to the
following schedule would have resulted in a greater number of
Long-Term Performance Units having been earned. For the avoidance
of doubt, the Committee may not use this discretion following a
Change of Control in accordance with Article 11 of the Plan.
The Financial Objectives shall be listed and shall be calculated in
the manner set forth in Exhibit 1 hereto.
|
|
|
|
|
|
|
King Pharmaceuticals, Inc. Annual
Performance v. stated
|
|
Payout—Percent of
Target
|
|
Financial
Objectives
|
|
Long-Term
Performance
|
|
During the Performance
Cycle
|
|
Units Granted
|
|
|
|
|
200
|
%
|
|
|
|
|
200
|
%
|
|
|
|
|
100
|
%
|
|
|
|
|
50
|
%
|
|
|
|
0% (no payout)
|
This Long-Term
Performance Unit Award is subject to and governed by the terms of
this Long-Term Performance Unit Award Certificate, the Long-Term
Performance Unit Award Agreement attached hereto and incorporated
by reference herein and the Company’s Incentive
Plan.
|
|
|
|
|
|
|
|
KING
PHARMACEUTICALS, INC.
|
|
|
|
By:
|
|
|
|
|
|
Name:
|
Brian A.
Markison
|
|
|
|
|
Title:
|
President and
Chief Executive Officer
|
|
|
|
2
LONG-TERM PERFORMANCE UNIT AWARD
AGREEMENT
(ONE YEAR PERFORMANCE CYCLE)
PURSUANT TO THE KING PHARMACEUTICALS, INC.
INCENTIVE PLAN
This Long-Term
Performance Unit Award Agreement (the “Agreement”) is
made as of the date set forth on the Long-Term Performance Unit
Award Certificate attached hereto (the “Grant Date”) by
King Pharmaceuticals, Inc. (the “Company”) and the
individual identified on the Long-Term Performance Unit Award
Certificate (the “Participant”) to grant a Long-Term
Performance Unit Award by the Company to the Participant on the
terms and conditions set forth below:
1.
LONG-TERM PERFORMANCE UNIT AWARD.
As of the Grant
Date, subject to the terms, conditions and restrictions set forth
herein, the Company grants and issues to the Participant a
Long-Term Performance Unit Award for such number of Long-Term
Performance Units as indicated on the Long-Term Performance Unit
Award Certificate (the “Long-Term Performance Units”)
which may be earned during the Performance Cycle as indicated on
the Long-Term Performance Unit Award Certificate if the Performance
Goals set forth on the Long-Term Performance Unit Award Certificate
are met.
The Long-Term
Performance Unit Award shall be granted pursuant to and (except as
specifically set forth herein) subject in all respects to the
applicable provisions of the King Pharmaceuticals, Inc. Incentive
Plan (“Plan”), which are incorporated herein by
reference. Terms not otherwise defined in this Agreement have the
meanings ascribed to them in the Plan.
3.
CALCULATION OF EARNED LONG-TERM PERFORMANCE
UNITS.
The Committee, in
its sole discretion, will determine the number of Long-Term
Performance Units earned by the Participant at the end of the
Performance Cycle based on the attainment of the Performance Goals
as set forth on the Long-Term Performance Unit Award Certificate.
The number of shares of Common Stock ultimately earned and paid, if
any, for such Long-Term Performance Units will be determined based
on the number of Long-Term Performance Units actually earned and
vested as set forth in Section 4 below, with one share of
Common Stock granted to the Participant for every earned and vested
Long-Term Performance Unit. Notwithstanding any other provision of
this Long-Term Performance Unit Award Agreement, upon the
completion of the Performance Cycle, the Committee may, in its sole
discretion, reduce the number of Long-Term Performance Units that
are actually earned by the Participant, irrespective of whether
adherence to the Performance Goals schedule provided in the
Long-Term Performance Unit Award Certificate would have resulted in
a greater number of Long-Term Performance Units having been earned.
For the avoidance of doubt, the Committee may not use this
discretion following a Change of Control in accordance with
Article 11 of the Plan.
Exhibit 1-1
4.
VESTING OF LONG-TERM PERFORMANCE UNITS.
Long-Term
Performance Units earned will vest as set forth below:
(a) Provided
the Participant has continued employment through the end of the
Vesting Period set forth in the Long-Term Performance Unit Award
Certificate, one hundred percent (100%) of the earned Long-Term
Performance Units shall vest on the last day of such Vesting
Period; or
(b) In
the event of the Participant’s Separation from Service by
reason of death, Disability, Approved Retirement, Cause or
resignation during the Performance Cycle, the vesting, forfeiture
and payment of Long-Term Performance Units shall be determined
according to Section 9.2 and Section 13.5 of the Plan, which
requires that all payments comply with Section 409A of the
Code. The portion of any Long-Term Performance Units which vest
upon one of the events discussed above pursuant to Section 9.2
of the Plan shall be paid to the Participant as soon as reasonably
practicable, with the payment date determined by the Company in its
sole discretion. In the case of Approved Retirement, the payment
due to the Participant under Section 9.2(c)(iii) shall be
calculated as if the target performance for each Long-Term
Performance Unit had, in fact, been achieved.
(c) In
the event of the Participant’s Separation from Service by
reason of death, Disability or Approved Retirement following the
completion of the Performance Cycle, but prior to the end of the
Vesting Period, one hundred percent (100%
|